More comebacks than Die Hard !
BNN Bloomberg reports…..
Linton is already eyeing his next move on the global cannabis stage, launching a Dublin-based investment fund named Oskare Capital later this week.
Linton said the fund will raise roughly 150-million euros in three tranches to support early-stage companies that develop medical and pharmaceutical products that could be later incorporated to utilize cannabinoids.
“We’re going to be picking up early-stage [intellectual property] used in other fields that aren’t cannabinoids and forming companies through something like an incubator,” he said. “So we’ll try to have some of the early tech that may be a bit out there that Big Pharma or Big [consumer-packaged goods] companies could one day be interested in.”
Aside from his work with Oskare, Linton said he is also fielding pitches for his Collective Growth Corp., a special purpose acquisition company that raised US$150 million when it went public on the Nasdaq last month, and is also becoming active in the burgeoning psychedelic space with board positions at Mind Medicine Inc. and Red Light Holland Corp.
He doesn’t appear to hold any animosity toward Vireo despite the termination, stating the company has good production assets and is well-positioned in certain U.S. states when they begin to legalize cannabis recreationally.
“It’s a good company, but probably when I’m around 82 years old, I’ll be more relaxed and that will be easier for me to stop thinking about taking over the world,” Linton said.
